Zogenix, Inc. announced that David Brushwood, J.D., R.Ph., recently-retired Professor Emeritus of Pharmaceutical Outcomes and Policy at the University of Florida, College of Pharmacy, has joined the company's External Safe Use Board. This group of independent experts is responsible for providing thorough feedback and recommendations regarding the use of Zohydro(R) ER (hydrocodone bitartrate) Extended-Release Capsules, CII.